These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. Knapp HR, Reilly IA, Alessandrini P, FitzGerald GA. N Engl J Med; 1986 Apr 10; 314(15):937-42. PubMed ID: 3007982 [Abstract] [Full Text] [Related]
6. Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse. McClelland S, Gawaz M, Kennerknecht E, Konrad CS, Sauer S, Schuerzinger K, Massberg S, Fitzgerald DJ, Belton O. Atherosclerosis; 2009 Jan 10; 202(1):84-91. PubMed ID: 18514659 [Abstract] [Full Text] [Related]
17. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. Jin YR, Cho MR, Ryu CK, Chung JH, Yuk DY, Hong JT, Lee KS, Lee JJ, Lee MY, Lim Y, Yun YP. J Pharmacol Exp Ther; 2005 Jan 10; 312(1):214-9. PubMed ID: 15328379 [Abstract] [Full Text] [Related]
18. Dietary fish and prostanoid formation in man. Hornstra G, van Houwelingen AC, Kivits GA, Fischer S, Uedelhoven W. Adv Prostaglandin Thromboxane Leukot Res; 1991 Jan 10; 21A():225-8. PubMed ID: 1825544 [Abstract] [Full Text] [Related]
19. Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction. Buccellati C, Ciceri P, Ballerio R, Casagrande C, Folco G, Nicosia S. Eur J Pharmacol; 2002 May 17; 443(1-3):133-41. PubMed ID: 12044803 [Abstract] [Full Text] [Related]